Elixinol Wellness Limited (ASX:EXL) Annual Report 2023



The latest annual report of Elixinol Wellness Limited (EXL) was published on 31 Dec 2023. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - EXL Annual Results

Amounts in AUD

Total Revenue
$8.27M
Gross Profit
$6.70M
EBIT
$-3.82M
Net Tangible Assets
$10.76M
Net Income
$-7.51M
Capital Expenditures
-

EXL Income Statement 2023 Annual Report

As per the latest Income Statement of EXL, the Net revenue increased by $1.21M (17%) compared to the previous period. The operating income in 2023 increased by - (-). The net income as per the annual report was $-7.51M which increased by - (-) compared to previous year.

Income Statement Report (2023/2022)

2023 2022
Total Revenue $8.27M $7.05M
Gross Profit $6.70M $6.70M
Operating Income - -
Income Before Tax - -
Net Income $-7.51M $0.00

Balance Sheet - EXL 2023 Annual Report

Read further: EXL Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Elixinol Wellness Limited showed the company increased the cash on balance sheet by $0.00 (0%). The Net tangible assets of EXL on the balance sheet were at $10.76M which is $0.00 (0%) more than previous annual report. The total stockholder equity also increased by - (-) compared to previous reporting period.

Balance Sheet Statement Report (2023/2022)

2023 2022
Cash $1.41M $1.41M
Total Assets - -
Long Term Debt - -
Total Liabilities $3.73M $3.73M
Total Shareholder Equity - -
Net Tangible Assets $10.76M $10.76M

Cash Flow Statement - EXL 2023 Annual Report

The 2023 annual cash flow statement of Elixinol Wellness Limited showed that the net income increased by - (-) compared to previous reporting period. Also the capital expenditure of EXL increased by - (-).

As of 2023, the total cash from investing activities was - and total cash from financing activities was -.

Cash Flow Statement Report (2023/2022)

2023 2022
Net Income $-7.51M $0.00
Capital Expenditures - -
Dividends Paid - -
Total Cash From From Investing Activities - -
Total Cash From From Financing Activities - -

Elixinol Wellness Limited Annual Report History

Income Statement

Income Statement history of Elixinol Wellness Limited (ASX:EXL)

31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2019
Total Revenue $8.27M $7.05M $0.00 $27.18M
Cost Of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Research Development - - - -
Selling General Administrative - - - -
Non Recurring - - - -
Other Operating Expenses - - - -
Total Operating Expenses $0.00 $0.00 $0.00 $0.00
Operating Income - - - -
Total Other Income Expense Net - - - -
Ebit $0.00 $0.00 $0.00 $0.00
Interest Expense - - - -
Income Before Tax - - - -
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Minority Interest - - - -
Net Income From Continuing Ops - - - -
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income $-7.51M $0.00 $-17.02M $-83.34M
Net Income Applicable To Common Shares - - - -

Balance Sheet Statement

Balance Sheet Statement history of Elixinol Wellness Limited (ASX:EXL)

31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2019
Cash $1.41M $1.41M - -
Total Assets - - - -
Total Liab $3.73M $3.73M - -
Long Term Debt - - - -
Total Stockholder Equity - - - -
Net Tangible Assets $10.76M $10.76M - -

Cash Flow Statement

Cash Flow Statement history of Elixinol Wellness Limited (ASX:EXL)

31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2019
Net Income $-7.51M $0.00 - -
Capital Expenditures - - - -
Dividends Paid - - - -
Total Cashflows From Investing Activities - - - -
Total Cash From Financing Activities - - - -